Study Stopped
PI is no longer at the institution
Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
1 other identifier
observational
5
1 country
1
Brief Summary
The purpose of the study is to prospectively assess the prevalence of venous thrombosis in women hospitalized for Cesarean Section, vaginal delivery or extended antepartum hospitalization by using Compression ultrasound of the entire proximal venous system of the lower limb veins.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 25, 2016
CompletedFirst Posted
Study publicly available on registry
March 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedJanuary 15, 2025
December 1, 2024
3.5 years
February 25, 2016
January 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of Venous Thrombosis in patients hospitalized for Cesarean Section, Vaginal delivery or any antepartum indication
48 hours (plus or minus 24 hours) after delivery.
Study Arms (1)
antepartum and postpartum
This prospective, observational cohort study was designed to assess the incidence of VTE in patients hospitalized for Cesarean Section, Vaginal delivery or any antepartum indication.
Interventions
This is a prospective observational cohort study.
Eligibility Criteria
All patients presenting to TCH/Women's Pavilion and Ben Taub Hospital for Cesarean Section, vaginal delivery or any antepartum hospitalization will considered for the study.
You may qualify if:
- All patients hospitalized for Cesarean Section,
- All patients hospitalized for vaginal delivery
- any other antepartum indication of hospitalization.
You may not qualify if:
- Psychiatric illness
- social situations that could limit compliance with study activities
- all patients who lack capacity to consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor College of Medicine
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Steven L Clark, M.D.
Baylor College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair
Study Record Dates
First Submitted
February 25, 2016
First Posted
March 3, 2016
Study Start
February 1, 2016
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
January 15, 2025
Record last verified: 2024-12